---
description: >-
  The global home infusion therapy market size reached US$ 37.5 Billion in 2021.
  Looking forward, IMARC Group expects the market to reach US$ 56.2 Billion by
  2027, exhibiting a growth rate
---

# Home Infusion Therapy Market Business Growth, Development Factors and Growth Analysis 2022-2027

According to the latest report by IMARC Group, titled “Home Infusion Therapy Market Size: Global Industry Trends, Share, Growth, Opportunity and Forecast 2022-2027,” The global [home infusion therapy market](https://www.imarcgroup.com/home-infusion-therapy-market) size reached **US$ 37.5 Billion in 2021**. Looking forward, IMARC Group expects the market to reach **US$ 56.2 Billion by 2027**, exhibiting a growth rate **(CAGR) of 7.17%** during 2022-2027.

**Report Metric**

Historical: 2016-2021

Base Year: 2020

Forecast Year: 2022-2027

**Download free sample of the report:** [https://www.imarcgroup.com/home-infusion-therapy-market/requestsample](https://www.imarcgroup.com/home-infusion-therapy-market/requestsample)

**Home Infusion Therapy Market Industry Definition and Application:**

Home infusion therapy refers to a medical procedure used in the intravenous (IV) or subcutaneous administration of drugs or biologics to a patient at home. It involves the infusion of medications like antivirals or immune globulin through pumps, vials, catheters, etc. This method is effective in chemotherapy and hydration, inotropic, enteral, anti-infective, nutritional, and pain management therapies for the treatment of diabetes and different gastrointestinal and oncological disorders. Besides this, it facilitates self-administration of drugs in medical conditions where oral medications are not effective.

**Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.**

**Home Infusion Therapy Market Trends and Drivers:**

The increasing cases of chronic medical ailments, like cancer, osteoarthritis, diabetes, etc., and shifting consumer preferences towards at-home treatments are primarily driving the global market for home infusion therapy. Moreover, the growing incidences of hospital-acquired infections (HAIs) upon exposure to contaminated equipment, bed linens, air droplets, etc., is also driving the demand for home infusion treatment. Additionally, the ongoing global COVID-19 pandemic is escalating the need for this therapy to minimize the spread of infection and ensuring optimal treatment. Additionally, the development of cost-effective, portable, and user-friendly home infusion kits that are equipped with advanced drip systems to facilitate precise and real-time monitoring of IV treatments is further contributing to the market growth. Besides this, the expanding geriatric population and improving healthcare infrastructures are anticipated to further propel the market growth in the coming years.

**Browse full report with TOC:** [https://www.imarcgroup.com/home-infusion-therapy-market](https://www.imarcgroup.com/home-infusion-therapy-market)

Home Infusion Therapy Market Segmentation:

The report has segmented the market on the basis on region, product and application.

**Breakup by Product:**

Infusion Pumps\
Elastomeric\
Electromechanical\
Gravity\
Others\
Intravenous Sets\
IV Cannulas\
Needleless Connectors

**Breakup by Application:**

Anti-Infective\
Endocrinology\
Diabetes\
Others\
Hydration Therapy\
Athletes\
Others\
Chemotherapy\
Enteral Nutrition\
Parenteral Nutrition\
Specialty Pharmaceuticals\
Others

**Breakup by Region:**

North America:( United States, Canada)\
Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)\
Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)\
Latin America: (Brazil, Mexico,Others)\
Middle East and Africa

**Who are the Major Home Infusion Therapy Market Key players?**

**The report provides a detailed analysis of the market leaders, including.**

B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Eli Lilly and Company, Fresenius SE & Co. KGaA, ICU Medical Inc., JMS Co. Ltd., Nipro Corporation, Option Care Health Inc. (Walgreen Co.), Smiths Group plc and Terumo Corporation.

**About Us**

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

**Contact Us**

Olivia Anderson\
Marketing Manager\
30 N Gould St, Ste R\
Sheridan, WY 82801, USA\
Email: sales@imarcgroup.com\
Website: https://www.imarcgroup.com\
LinkedIn: https://in.linkedin.com/company/imarc-group
